글로벌 디지털 필 시장 – 2031년까지의 산업 동향 및 예측

디지털 필 시장 분석 및 규모

디지털 알약 시장의 핵심 응용 분야인 약물 복용 모니터링은 알약에 내장된 센서를 사용하여 환자의 약물 섭취를 실시간으로 추적하는 것을 포함합니다. 이 기술을 통해 의료 서비스 제공자는 환자가 처방된 약물을 지시대로 복용하고 있는지 원격으로 모니터링할 수 있습니다. 섭취 패턴과 복용 수준에 대한 데이터를 수신한 의료 전문가는 비복용 문제를 해결하고 치료 계획을 개인화하며 환자 결과를 개선하기 위해 신속하게 개입할 수 있습니다. 이 응용 프로그램은 효과적인 질병 관리와 합병증 예방을 위해 약물 요법을 준수하는 것이 중요한 만성 질환을 관리하는 데 특히 유용합니다.

글로벌 디지털 알약 시장 규모는 2023년에 42억 7천만 달러로 평가되었으며, 2031년까지 81억 2천만 달러에 도달할 것으로 예상되며, 2024년에서 2031년까지의 예측 기간 동안 CAGR은 8.35%입니다. Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

보고 범위 및 시장 세분화       

시장 정의

디지털 알약은 섭취를 추적하고 외부 장치로 데이터를 전송하는 센서가 내장된 삼키는 약물입니다. 이 혁신적인 알약은 약물 복용을 개선하고, 환자 건강을 원격으로 모니터링하고, 치료 효과에 대한 실시간 통찰력을 제공하여 전반적인 의료 관리를 개선하는 것을 목표로 합니다.

디지털 필 시장 동향

운전자                                                                                          

• 디지털 필의 높은 기술 발전 증가

센서 기술, 소형화, 무선 연결의 획기적인 발전으로 점점 더 정교해지는 디지털 알약의 개발이 가능해졌습니다. 이러한 발전은 디지털 알약의 정확성, 신뢰성, 사용성을 향상시켜 환자와 의료 서비스 제공자 모두에게 더욱 실용적이고 매력적으로 만들었습니다. 데이터 분석과 인공 지능 의 개선 으로 디지털 알약의 기능이 더욱 강화되어 실시간 모니터링, 개인화된 치료 조정, 환자 건강에 대한 예측적 통찰력이 가능해졌습니다. 기술이 계속 발전함에 따라 디지털 알약은 약물 복용 준수, 원격 환자 모니터링, 전반적인 의료 서비스 제공에 혁명을 일으킬 수 있는 가능성을 가지고 있습니다.

예를 들어, EtectRx ID-Cap System의 FDA 승인은 기술적 발전이 디지털 알약 시장을 어떻게 발전시키는지 보여줍니다. 혁신적인 센서 기술을 활용한 이 시스템은 섭취 가능한 디지털 알약에서 외부 의료 기기로 준수 이벤트 로그를 전송할 수 있습니다. 이러한 발전은 약물 준수 모니터링을 개선하고 디지털 알약이 의료 서비스 제공을 혁신하는 데 점점 더 정교해지고 실용성이 높아지고 있음을 보여줍니다.

• 고령화 인구 증가로 디지털 알약 의 급속한 도입

As people age, they are more such asly to develop chronic diseases requiring long-term medication management, often with multiple prescriptions. Digital pills offer a solution by improving medication adherence through real-time monitoring and reminders, addressing the challenges of polypharmacy and medication complexity commonly faced by the elderly. Additionally, digital pills enable remote monitoring of medication intake and health status, allowing caregivers and healthcare providers to intervene promptly in case of non-adherence or adverse events, thereby enhancing the overall quality of care for aging populations.

Opportunities

• Escalating Prevalence of Chronic Diseases Increases the Adoption of Digital Pills

Digital pills for mental health, cardiovascular ailments and other chronic diseases often require long-term management and precise medication adherence for effective treatment outcomes. Digital pills offer a solution by enabling real-time monitoring of medication ingestion, enhancing patient adherence, and providing healthcare providers with valuable insights into patient behavior. Addressing the challenge of medication non-adherence, digital pills help mitigate the risk of disease complications, hospitalizations, and healthcare costs associated with chronic conditions. As the burden of chronic diseases continues to rise globally, the demand for innovative solutions such as digital pills to optimize disease management and improve patient outcomes is expected to grow substantially.

• High Supportive Regulatory Environment Increases Adoption of  Digital Pills

Regulatory agencies worldwide are recognizing the potential benefits of digital pills in improving medication adherence, remote patient monitoring, and personalized medicine. Establishing clear guidelines and frameworks for the development, approval, and commercialization of digital pills, regulators provide confidence to manufacturers, healthcare providers, and patients, facilitating market growth. This supportive regulatory landscape encourages collaboration between stakeholders, accelerates technology advancements, and ultimately expands the reach and impact of digital pills in improving healthcare outcomes.

Restraints/Challenges

• High Cost Limits the Adoption of Digital Pills

Integrating advanced sensors, connectivity components, and digital infrastructure increases the production and development expenses, making digital pills costly for healthcare providers and patient’s alike. Moreover, the need for ongoing maintenance, data management, and technical support further adds to the total cost of ownership. These high upfront and recurring costs pose financial barriers, particularly for healthcare systems with limited budgets or patients without adequate insurance coverage, limiting the accessibility and affordability of digital pills and impeding their adoption on a larger scale.

• Growing Privacy Concerns limits the Demand of Digital Pills

The collection and transmission of sensitive health data by these devices raise apprehensions about patient privacy and data security. Patients may be reluctant to use digital pills due to fears of unauthorized access to their medical information or potential breaches. Healthcare organizations also face challenges in ensuring compliance with privacy regulations such as HIPAA, adding complexity to implementation.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In August 2020, GlaxoSmithKline plc's launch of its digital health platform, Tesaro, Inc., signifies the pharmaceutical giant's strategic entry into the digital pills market, aiming to revolutionize healthcare delivery through innovative technology. This move aligns with the trend of pharmaceutical companies embracing digital solutions to enhance patient care and treatment adherence, driving market expansion
• In July 2020, Otsuka Pharmaceutical Co., Ltd.'s collaboration with Proteus Digital Health underscores a proactive approach towards developing digital health solutions, including potential applications in the digital pills sector. This partnership reflects the growing recognition among pharmaceutical companies of the importance of integrating digital technologies to address healthcare challenges and improve patient outcomes
• In July 2020, Otsuka Pharmaceutical Co., Ltd.'s launch of digital health solutions for chronic diseases highlights the company's commitment to leveraging technology to address unmet medical needs, potentially extending into the realm of digital pills. Introducing tailored digital solutions, Otsuka aims to enhance disease management and treatment adherence, fostering market growth and patient well-being
• In June 2020, Novartis AG's acquisition of Healthymize, an AI-driven digital health company, displays the pharmaceutical giant's strategic investment in digital health technologies, including those relevant to the digital pills market. This acquisition bolsters Novartis' capabilities in leveraging artificial intelligence for remote patient monitoring and personalized healthcare solutions, contributing to the advancement of the digital pills sector and overall healthcare innovation

Digital Pills Market Scope

The market is segmented on the basis of product type, indication, distribution channel, diseases and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

• Tablet
• Capsule
• Microchip Delivery Device

Indication

• Mental Disorders
• Cancer
• Infectious Diseases
• Others

Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Specialty Pharmacies
• Mail Order Pharmacies

Diseases

• Cardiovascular Diseases
• Infectious Diseases
• Diabetes
• Cancer
• Others

End-User

• Hospitals
• Clinics
• Home Care Settings
• Others

Digital Pills Market Regional Analysis/Insights

The market is analysed and market size insights and trends are provided by country, product type, indication, distribution channel, diseases and end-user as referenced above.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the market due to manufacturers' adeptness in utilizing advanced tracking technologies and significant R&D investments. Moreover, the region witnesses a surge in diseases such as diabetes and cardiovascular disorders, driving the demand for innovative healthcare solutions. Additionally, the adoption of digital pills fosters improved adherence to treatment regimens, resulting in faster recovery times among patients, further fueling market growth in North America.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

이 시장은 또한 자본 장비에 대한 의료 지출의 모든 국가별 성장, 시장에 대한 다양한 종류의 제품의 설치 기반, 수명선 곡선을 사용한 기술의 영향, 의료 규제 시나리오의 변화 및 시장에 미치는 영향에 대한 자세한 시장 분석을 제공합니다. 이 데이터는 2016-2021년의 과거 기간에 대해 제공됩니다.

경쟁 환경 및 디지털 필 시장 분석

시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 애플리케이션 우세입니다. 위에 제공된 데이터 포인트는 시장과 관련된 회사의 초점에만 관련이 있습니다.

시장에서 활동하는 주요 기업은 다음과 같습니다.

• 2MORROW 주식회사 (미국)
• 오츠카 홀딩스 주식회사(일본), 퓨어테크(미국)
• Teladoc Health, Inc. (미국)
• AliveCor, Inc.(미국)
• 애벗(미국)
• 올림푸스 주식회사(일본)
•  메드트로닉(아일랜드)
• 스미스+네퓨(영국)
• 노바티스 AG(스위스)
• 오마다 헬스 주식회사(미국)
• 모카케어(미국)
• GENTAG, Inc. (미국)
• Zio by iRhythm Technologies, Inc. (미국)
• 퍼피션트 주식회사(미국)
• BDD Ltd(영국)
• CapsoVision, Inc. (미국)
• 웰닥 주식회사(미국)

SKU-15501